In these cases, you already know the medication works in your body
It contains the same drug at the same doses, so theres no clinical difference between the two
Injection site rotation Rotate injection sites with each weekly dose

a) Coupling of Fmoc-Gly-OH with Resin in a solvent and a base by solid phase peptide synthesis to provide Fmoc-Gly-Resin, b) treating Fmoc-Gly-Resin with a deprotecting agent to provide H-Gly-Resin, c) coupling of Fmoc-Arg(pbf)-OH to H-Gly-Resin in a solvent optionally in presence of a coupling agent and/or a base to provide Fmoc-Arg(Pbf)-Gly-Resin, d) treating Fmoc-Arg(Pbf)-Gly-Resin with a deprotecting agent to provide H-Arg(Pbf)- Gly-Resin, e) repeating the coupling and deprotection steps with remaining amino acids Fmoc-Gly- OH, Fmoc-Arg(pbf)-OH, Fmoc-Val-OH, Fmoc-Leu-OH, Fmoc-Trp(Boc)-OH, Fmoc- Ala-OH, Fmoc-Ile-OH, Fmoc-Phe-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Ala-OH, Fmoc-Ala-OH, Fmoc-Gln(Trt)-OH, Fmoc-Gly-OH, Fmoc-Glu(OtBu)- OH, Fmoc-Leu-OH, Fmoc-Tyr(tBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Val-OH, Fmoc-Asp(OtBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Thr(tBu)-OH, Fmoc- Phe-OH, Fmoc-Thr(tBu)-OH, Fmoc-Gly-OH, Fmoc-Glu(OtBu)-OH by linear approach as per the amino acid sequence in Semaglutide backbone in a solvent optionally in presence of a coupling agent and/or a base
